Journal of Immunology Research / 2019 / Article / Tab 5

Research Article

Comparative Serological Study for the Prevalence of Anti-MERS Coronavirus Antibodies in High- and Low-Risk Groups in Qatar

Table 5

Cross-reactivity of reactive samples with rS1-ELISA and other human coronaviruses.

Sample identifierWhole-virus IIFT IgG titerrS1-ELISA titer IgGrS1-IIFT titer IgG
229ESARSHKU1229EOC43SARSNL63HKU1

Reactive BDBD 2014/597≥3200≥100320320032003200
BD 2015/13033200≥1013200320003200320
BD 2015/3004≥10000≥1013203200032003200
BD 2015/3119≥3200≥1013203200320320
BD 2015/33803200≥101320032000320320
BD 2015/3513≥10000≥10132003200032003200
BD 2015/4435≥3200≥1013203200032003200
Borderline BDBD 2012/2644≥10000≥1013203200320320
BD 2015/1816≥3200≥10132003200032003200
BD 2015/4708NDND≥1013200320003203200
Selected negative BD (showing 3/13)BD 2015/2859NDNDND32003200032003200
BD 2015/2988NDNDND32032000320
BD 2015/3379320 (IgM = 0)0 (IgM = 0)≥101320032000320320
Reactive CPCP Mar.20151000≥1013200320320320320
CP May.201510000≥1013200320003203200
CP Feb.201601000≥1013200>10000320000

Positive samples are shown in italic. ND: not determined.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.